The role of reoperation in the management of endometrial carcinoma found in simple hysterectomy

Journal of Surgical Oncology

Volumn 93, Issue 5, 2006, Pages 373-378

  Ayhan, Ali ^a   Kart, Cavit ^a   Guven, Suleyman ^a,b   Boynukalin, Kubra ^a   Kucukali, Turkan ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Endometrial cancer; Hysterectomy; Lympadenectomy; Recurrence; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; ENDOMETRIUM CARCINOMA; EVALUATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYSTERECTOMY; MINIMAL RESIDUAL DISEASE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE RISK; REOPERATION; RETROSPECTIVE STUDY; SURVIVAL RATE; SYSTEMATIC REVIEW; ENDOMETRIUM TUMOR; LYMPHADENECTOMY; MIDDLE AGED; MORTALITY; PATHOLOGY; STATISTICAL MODEL; TUMOR RECURRENCE; TURKEY (REPUBLIC);

ADULT; AGED; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; LOGISTIC MODELS; LYMPH NODE EXCISION; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; REOPERATION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TURKEY;

EID: 33646201952     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20479     Document Type: Article

References (14)

1. Jemal A, Murray T, Ward E, et al.: Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10-30.
2. FIGO: Corpus cancer staging. Int J Gynecol Obstet 1989;28:190.
3. Boronow RC, Morrow CP, Creasman WT, et al.: Surgical staging in endometrial cancer: Clinical-pathologic findings of a prospective study. Obstet Gynecol 1984;63:825-832.
4. Creasman WT, Morrow CP, Bundy BN, et al.: Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study. Cancer 1987;60:2035-2041.
5. Yokoyama Y, Maruyama H, Sato S, et al.: Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancer. Gynecol Oncol 1997;64:411-417
6. Munstedt K, Grant P, Woenckhaus J, et al.: Cancer of the endometrium: Current aspects of diagnostics and treatment. World J Surg Oncol 2004;21:2-24.
7. Mariani A, Webb MJ, Keeney GL, et al.: Low-risk corpus cancer: Is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 2000;182:1506-1519.
8. Ceccaroni M, Savelli L, Bovicelli A, et al.: Prognostic value of pelvic lymphadenectomy in surgical treatment of apparent stage I endometrial cancer. Anticancer Res 2004;24:2073-2078.
9. Descamps P, Body G, Calais G, et al.: [Stage I and II endometrial cancer: Should lymphadenectomy still be done?] J Gynecol Obstet Biol Reprod (Paris) 1995;24:794-801 (abstract).
10. Lo KW, Cheung TH, Yu MY, et al.: The value of pelvic and para-aortic lymphadenectomy in endometrial cancer to avoid unnecessary radiotherapy. Int J Gynecol Cancer 2003;13:863-869.
11. COSA-NZ-UK Endometrial Cancer Study Groups: Pelvic lymphadenectomy in high risk endometrial cancer. Int J Gynecol Cancer 1996;6:102-107.
12. Bar-Am A, Ron IG, Kuperminc M, et al.: The role of routine pelvic lymph node sampling in patients with stage I endometrial carcinoma: Second thoughts. Acta Obstet Gynecol Scand 1998;77:347-350.
13. Larson DM, Johnson K, Olson KA: Pelvic and para-aortic lymphadenectomy for surgical staging of endometrial cancer: Morbidity and mortality. Obstet Gynecol 1992;79:998-1001.
14. Creutzberg CL, van Putten WL, Koper PC, et al.: Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial. PORTEC Study Group Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 2000;355:1404-1411.